A recent study showed that pioglitazone treatment of ob/ob mice improves insulin resistance and diabetes by increasing serum adiponectin levels and decreasing hepatic glucose production (Kubota et al., 2006). This evidence concerns the gene ADIPOQ and Insulin resistance.